Aktuellt
SENASTE
Preliminary data indicate that Orviglance has been well-tolerated in the Food Efficacy Study, which will be part of the submission package for both FDA and EMA. The final results from this Food Effect Study are expected within four months. The Food Efficacy Study is one out of two supporting studies besides the main pivotal Mangoral study.
LÄS MER
